搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
healthday
3 天
Collagenase Not Noninferior for Dupuytren Contracture
For patients with moderate Dupuytren contracture, collagenase injection is not noninferior to limited fasciectomy, acc ...
precisionmedicineonline
3 天
Bluebird Bio's Skysona Continues to Benefit Patients Years Later, but Some Develop Blood Cancer
Seven of 67 patients who received the cerebral adrenoleukodystrophy gene therapy developed blood cancer, though most cases ...
HealthDay on MSN
3 天
Hematologic Cancer Develops in Some Patients Receiving Eli-Cel
Hematologic cancer develops in some patients receiving lentiviral elivaldogene autotemcel (eli-cel) gene therapy for cerebral ...
4 天
Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...
BioPharma Dive
4 天
New data underline cancer risk of Bluebird therapy for brain disease
Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.
6 天
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈